Drug Interaction Report

Apixaban and Methylprednisolone: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Methylprednisolone

Depo-Medrol HybriSil
+

Apixaban

Eliquis Eliquis®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 289 documented Apixaban interactions, 34 are rated moderate — including this one.
At a glance + Effects may be stronger
The Bottom Line
Combining apixaban with methylprednisolone can raise your risk of bleeding, especially in the gut, so watch for bleeding signs and let your care team monitor you. Keep taking both as prescribed and report any black stools, blood, or unusual bruising right away.

Taking these together can raise your risk of bleeding, especially in your stomach or gut. Apixaban (Eliquis) is a blood thinner, and methylprednisolone is a steroid. Steroids can irritate the stomach lining, and when you add a blood thinner, any bleeding that starts can be harder to stop. This risk goes up with higher steroid doses.

The good news is that this is very manageable. Keep taking both exactly as prescribed, and watch for warning signs like black or tarry stools, red or brown vomit, or unusual bruising. Your care team can keep an eye on you and adjust things if needed. Talk with your pharmacist or doctor if you have questions.

Effect: Additive increase in bleeding risk, particularly gastrointestinal bleeding, when apixaban is combined with an oral glucocorticoid.

  • Direction/mechanism: Pharmacodynamic. Apixaban (direct factor Xa inhibitor) impairs hemostasis while glucocorticoids can promote GI mucosal injury; precise mechanism unspecified. Neither agent depends on activation, so this is a PD, not PK, interaction.
  • Magnitude/onset: Cohort data show higher GIB rates with concomitant use; risk rises with higher glucocorticoid doses and baseline bleeding risk. Onset unspecified.
  • Evidence: Probable.
  • Management: If coadministration is necessary, monitor closely for bleeding, especially at higher steroid doses and in high-bleeding-risk patients.
Onset
unspecified
Evidence
probable
Severity
Moderate

What happens

Increased risk of gastrointestinal bleeding

Interaction Deep Dive

Taking apixaban together with an oral glucocorticoid can raise the likelihood of bleeding1, including bleeding in the gastrointestinal tract (GIB). A cohort study found that individuals who had been prescribed non-vitamin K oral anticoagulants (NOACs) alongside oral glucocorticoids within the previous 60 days had a greater incidence of GIB than those without a glucocorticoid prescription; this elevated risk was seen at higher glucocorticoid doses and among patients with a greater tendency toward bleeding 2. When the two must be given together, careful monitoring is advised 21.

Why it happens (mechanism)

Precise mechanism unknown

How to manage this interaction

This interaction can usually be managed with close monitoring. Do not start or stop either medication on your own. Keep taking both as prescribed unless your care team tells you otherwise.

  • Your care team may watch you more closely for bleeding, particularly if you are on a higher steroid dose or already have a higher bleeding risk.
  • Steroid dosing may be individualized by your team to the lowest effective course.
  • Report warning signs promptly: black or tarry stools, blood in vomit or stool, ongoing stomach pain, unusual bruising, or bleeding that will not stop.
  • Ask your pharmacist before adding NSAIDs like ibuprofen or aspirin, which can add to bleeding risk.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) In a nested case-control study drawn from a large cohort of Danish adults with atrial fibrillation (N=98,376; median age 75 years; 44% female; 16% exposed to glucocorticoids; 35% receiving apixaban), simultaneous use of non-vitamin K oral anticoagulants (NOACs) with oral glucocorticoids was linked to a higher risk of gastrointestinal bleeding (GIB) than NOACs used alone. In patients who had been prescribed oral glucocorticoids at an equipotent dose below 20 mg of daily predniSOLONE during the previous 60 days (n=727), GIB occurred in 25% compared with 16% in the unexposed control group (n=28,363) [HR, 1.54; 95% CI, 1.29 to 1.84]. Relative to no exposure, this risk rose further when an equipotent dose of 20 mg predniSOLONE or more per day was prescribed (n=536), with 32% of this group experiencing GIB [HR, 2.19; 95% CI, 1.81 to 2.65]. Most glucocorticoid prescriptions were for oral predniSOLONE (84.5%), and inflammatory lung disease was the most frequent indication (30.8%). Additional indications comprised rheumatic disease (8.4%) and cancer (8.1%); nonetheless, a non-specific or unknown glucocorticoid indication was documented in 52.6% of the exposed group. Patients in the exposure group had a recorded prescription for any glucocorticoid within the 60 days before GIB, but detailed information about the duration of glucocorticoid treatment and the timing of treatment relative to the GIB hospitalization was not reported 2.

Common questions

Can I take Apixaban and Methylprednisolone together?

Combining apixaban with methylprednisolone can raise your risk of bleeding, especially in the gut, so watch for bleeding signs and let your care team monitor you. Keep taking both as prescribed and report any black stools, blood, or unusual bruising right away. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Apixaban and Methylprednisolone interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Apixaban and Methylprednisolone interaction managed?

This interaction can usually be managed with close monitoring. Do not start or stop either medication on your own. Keep taking both as prescribed unless your care team tells you otherwise. Your care team may watch you more closely for bleeding, particularly if you are on a higher steroid dose or already have a higher bleeding risk. Steroid dosing may be individualized by your team to the lowest ef… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Apixaban or Methylprednisolone need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (2)

  1. Steffel J, Collins R, Antz M, et al: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021; 23(10):1612-1676.
  2. Holt A, Blanche P, Zareini B, et al: Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants. Heart 2022; 108(8):626-632. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.